Gavin Clunie

Industry expert


Gavin Clunie

Cambridge University Hospitals NHS Foundation Trust

Consultant Rheumatologist and Metabolic Bone Physician

Dr Clunie trained at UCL completing a BSc in Human Genetics, then after graduating in medicine, pursued a postgraduate Medical Doctorate in the use of radiopharmaceuticals and imaging their effect as applied to musculoskeletal disease. He completed his Rheumatology specialist training in London and was appointed Consultant Rheumatologist in Ipswich in 2000. Dr Clunie had by then developed an interest in metabolic bone diseases having trained for a year at The Royal National Orthopedic Hospital and run the UCLH DXA Unit for 3 years. In Ipswich Dr Clunie set up and ran a DXA scanning service and Metabolic Bone Unit creating England’s first Fracture Liaison Service. Since that time the Service has become a beacon service, used as a template for similar services implemented in The UK and worldwide. Dr Clunie’s Metabolic Bone Disease interest includes the development of clinical services for rare diseases, having set up the forum for bringing together research scientists and clinicians regularly under the auspices of The Bone Research Society.

Dr Clunie moved to Cambridge in 2012 to lead the Clinical Metabolic Bone Service and has recently developed The Rare Bone Disease Network for the region (ERBON). Previous roles include: Regional Rheumatology Training Programme Director, Chair Regional Training Committee Rheumatology, Chair of British Society of Rheumatology (BSR) External Relations Committee, BSR lead for commissioning services, Regional representative for Rheumatology Specialist Services to NHS England Clinical Reference Group, and BSR representative to The Falls and Fragility Fractures Network at RCP.

Dr Clunie has also edited and written medical textbooks (Oxford Handbook of Rheumatology now in its 4th edition, Oxford Library Series: ‘Osteoporosis’, Oxford Desk Reference of Rheumatology) and has authored numerous chapters for other textbooks.


By continuing to use the site you agree to our cookies policy. Accept